Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Agents for HCV infection from ViroPharma

Dec. 11, 1997

Immunex and Digital Gene Technologies form genomics alliance

Dec. 10, 1997

Schering-Plough submits NDA for Intron A + ribavirin

Dec. 10, 1997

Novel liver-targeted conjugate for hepatitis B virus infection

Dec. 9, 1997

Efficacy of TxA2 antagonist in IBD established

Dec. 9, 1997

Another ANDA approval for Gensia

Dec. 8, 1997

Beneficial effects of PLA2 inhibitor in animal models of acute pancreatitis and ARDS

Dec. 8, 1997

Therapeutic potential of PC-SOD evaluated preclinically

Dec. 5, 1997

OR-1384 at least equieffective to 5-ASA in acute and chronic colitis in mice

Dec. 5, 1997

HCV protease inhibitors to be designed and developed by BMS and Arris

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...